Guidelines for the derivation of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop

Regulatory Toxicology and Pharmacology

Volumn 51, Issue 3 SUPPL., 2008, Pages

  Hays, Sean M ^a   Aylward, Lesa L ^a   LaKind, Judy S ^b   Bartels, Michael J ^c   Barton, Hugh A ^d   Boogaard, Peter J ^e   Brunk, Conrad ^f   DiZio, Stephen ^g   Dourson, Michael ^h   Goldstein, Daniel A ⁱ   Lipscomb, John ^d   Kilpatrick, Michael E ^j   Krewski, Daniel ^k   Krishnan, Kannan ^l   Nordberg, Monica ^m   Okino, Miles ^d   Tan, Yu Mei ⁿ   Viau, Claude ^l   Yager, Janice W ^o  

^a LLP   (United States)

^b LaKind Associates LLC   (United States)

^c DOW CHEMICAL COMPANY   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e SHELL GLOBAL SOLUTIONS INTERNATIONAL B V   (United States)

^f UNIVERSITY OF VICTORIA   (Canada)

^g Interstate Technology and Regulatory Council   (United States)

^h Toxicology Excellence for Risk Assessment   (United States)

ⁱ MONSANTO COMPANY   (United States)

^j Force Health Protection and Readiness Programs ^*  (United States)

^k UNIVERSITY OF OTTAWA   (Canada)

^l UNIVERSITÉ DE MONTRÉAL   (Canada)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^o UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

BEs; Biomonitoring; Biomonitoring Equivalents; Exposure guidance values; Risk assessment

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BIOEQUIVALENCE; BIOLOGICAL MONITORING; CALCULATION; CANCER RISK; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HUMAN; KINETICS; NEOPLASM; NONHUMAN; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT; SCREENING; TECHNOLOGY; TOXICOLOGY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL MONITORING; HUMANS; MODELS, ANIMAL; MODELS, BIOLOGICAL; PUBLIC HEALTH; RISK ASSESSMENT; XENOBIOTICS;

ANIMALIA;

EID: 47549112161     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.05.004     Document Type: Article

References (31)

1. Andersen M.E. Tissue dosimetry in risk assessment, or what's the problem here anyway?. Drinking Water Health 8 (1987) 8-23
2. Andersen M.E. What do we mean by...dose?. Inhal. Toxicol. 7 (1995) 909-915
3. Andersen M.E., Clewell III H., and Krishnan K. Tissue dosimetry, pharmacokinetic modeling, and interspecies scaling factors. Risk Anal. 15 4 (1995) 533-537
4. Aylward L.L., and Hays S.M. Biomonotoring Equivalents (BEs) dossier for toluene (CAS No. 108-88-3). Regul. Toxicol. Pharmacol. 51 (2008) S27-S36
5. Bahadori T., Phillips R.D., Money C.D., Quackenboss J.J., Clewell H.J., Bus J.S., Robison S.H., Humphris C.J., Parekh A.A., Osborn K., and Kauffman R.M. Making sense of human biomonitoring data: findings and recommendations of a workshop. J. Expo. Sci. Environ. Epidemiol. 17 4 (2007) 308-313
6. Ballauff A., Kersting M., and Manz F. Do children have an adequate fluid intake? Water balance studies carried out at home. Ann. Nutr. Metab. 32 5-6 (1988) 332-339
7. Barton H.A., Pastoor T.P., Baetcke K., Chambers J.E., Diliberto J., Doerrer N.G., Driver J.H., Hastings C.E., Iyengar S., Krieger R., Stahl B., and Timchalk C. The acquisition and application of absorption, distribution, metabolism, and excretion (ADME) data in agricultural chemical safety assessments. Crit. Rev. Toxicol. 36 1 (2006) 9-35
8. Bingham S.A., Williams R., Cole T.J., Price C.P., and Cummings J.H. Reference values for analytes of 24-h urine collections known to be complete. Ann. Clin. Biochem. 25 Part 6 (1988) 610-619
9. Boeniger M.F., Lowry L.K., and Rosenberg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am. Ind. Hyg. Assoc. J. 54 10 (1993) 615-627
10. Dorne J.L.C.M., Walton K., and Renwick A.G. Uncertainty factors for chemical risk assessment: human variability in the toxicokinetics of CYP1A2 probe substrates. Food Chem. Toxicol. 39 (2001) 681-696
11. Dorne J.L., and Renwick A.G. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans. Toxicol. Sci. 86 1 (2005) 20-26
12. ECETOC, 2005. Guidance for the Interpretation of Biomonitoring Data, ECETOX Dox. No. 44, Brussels.
13. Fiserova-Bergerova V. Development of biological exposure indices (BEIs) and their implementation. Appl. Ind. Hyg. 2 (1987) 87-92
14. Fiserova-Bergerova V. Application of toxicokinetic models to establish biological exposure indicators. Ann. Occup. Hyg. 34 (1990) 639-651
15. Hays S.M., and Aylward L.L. Biomonitoring Equivalents (BEs dossier) for acrylamid (AA) (CAS No. 79-06-1). Regul. Toxicol. Pharmacol. 51 (2008) S57-S67
16. Hays S.M., Becker R.A., Leung H.W., Aylward L.L., and Pyatt D.W. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective. Regul. Toxicol. Pharmacol. 47 1 (2007) 96-109
17. IPCS (International Programme on Chemical Safety), 2005. Chemical-specific adjustment factors for interspecies differences and human variability: guidance document for use of data in dose/concentration-response assessment. World Health Organization, Geneva. Available from: http://www.inchem.org/documents/harmproj/harmproj/harmproj2.pdf.
18. Kissel J.C., Curl C.L., Kedan G., Lu C., Griffith W., Barr D.B., Needham L.L., and Fenske R.A. Comparison of organophosphorus pesticide metabolite levels in single and multiple daily urine samples collected from preschool children in Washington state. J. Expo. Anal. Environ. Epidemiol. 15 (2005) 164-171
19. Kroes R., Renwick A.G., Cheeseman M., Kleiner J., Mangelsdorf I., Piersma A., Schiltter B., Schlatter J., van Schothorst F., Vos J.G., and Wurtzen G. Structure based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Foot Chem. Toxicol. 42 (2004) 65-83
20. LaKind J.S., Aylward L.L., Brunk C., DiZio S., Dourson M., Goldstien D.A., Kilpatrick M.E., Krewski D., Bartels M.J., Barton H.A., Boogaard P.J., Lipscomb J., Krishnan K., Nordberg M., Okino M., Tan Y.-M., Viau C., Yager J.W., and Hays S.M. Guidelines for the communication of Biomonitoring Eqivalents: Report from the Biomonitoring Equivalents Expert Workshop. Regul. Toxicol. Pharmacol. 51 (2008) S16-S26
21. Morgan M.S. The biological exposure indices: a key component in protecting workers from toxic chemicals. Environ. Health Perspect. 105 (1997) 105-115
22. National Research Council (NRC), 2006. Human Biomonitoring for Environmental Chemicals. National Academies Press, Washington, DC.
23. Newman D.J., Pugia M.J., Lott J.A., Wallace J.F., and Hiar A.M. Urinary protein and albumin excretion corrected by creatinine and specific gravity. Clin. Chim. Acta 294 (2000) 139-155
24. Rappaport S.M., Symanski E., Yager J.W., and Kupper L.L. The relationship between environmental monitoring and biological markers in exposure assessment. Environ. Health Perspect. 103 (1995) 49-53
25. Remer T., Fonteyn N., Alexy U., and Berkemeyer S. Longitudinal examination of 24-h urinary iodine excretion in schoolchildren as a sensitive, hydration status-independent research tool for studying iodine status. Am. J. Clin. Nutr. 83 (2006) 639-646
26. Remer T., Neubert A., and Maser-Gluth C. Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am. J. Clin. Nutr. 75 (2002) 561-569
27. Saghir S.A., Mendrala A.L., Bartels M.J., Day S.J., Hansen S.C., Sushynski J.M., and Bus J.S. Strategies to assess systemic exposure of chemicals in subchronic/chronic diet and drinking water studies. Toxicol. Appl. Pharmacol. 211 (2006) 245-260
28. Scher D.P., Alexander B.H., Adgate J.L., Eberly L.E., Mandel J.S., Acquavella J.F., Bartels M.J., and Brzak K.A. Agreement of pesticide biomarkers between morning void and 24-h urine samples from farmers and their children. J. Exp. Sci. Environ. Epidemiol. 17 (2007) 350-357
29. USEPA, 1999. Toxicological Profile for Ethylene Glycol Monobuty Ether (EGBE) (CAS No. 111-76-2). In Support of Summary Information on the Integrated Risk Information System (IRIS).
30. USEPA, 2002. A Review of the Reference Dose and Reference Concentration Processes. Risk Assessment Forum. EPA /630/P-02/002F.
31. Yager J.W. Development of biological monitoring as a tool for exposure assessment. In: Rappaport S.M., and Smith T.J. (Eds). Exposure Assessment for Epidemiology and Hazard Control (1990), Lewis Publishers, Inc., Chelsea, MI 115-130 (Chapter 8)